ALISHA COOLEY: Open Payments
NPI 1851699060 · SOMERSET, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 39 payments from 13 companies in 2025. Trend: 2023 $475 · 2024 $430 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $368 |
| Lilly USA, LLC | 3 | $49 |
| Cipher Pharmaceuticals US LLC | 1 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Alkermes, Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: RINVOQ, VRAYLAR, QULIPTA, MOUNJARO, Natroba, UBRELVY, CAPLYTA, ARISTADA.
Industry payments across KY — which companies pay providers there.
